MedPath

The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project

Not Applicable
Terminated
Conditions
HIV
Interventions
Behavioral: Reducing Risk Behavior
Behavioral: Support and Guidance
Registration Number
NCT02562092
Lead Sponsor
Emory University
Brief Summary

This study aims to understand the barriers to receiving HIV testing and retention of care for at risk and HIV positive young adults. This study also seeks to determine the feasibility and acceptability of HIV testing in a non-clinical setting.

Detailed Description

This study aims to identify factors that can facilitate or impede the use of non-clinical HIV testing venues as well as identify potential testing sites and assess acceptability of an HIV prevention intervention. In addition, the study will implement a pilot intervention to test the feasibility non-clinical HIV testing and follow up events for HIV positive youth.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Sexually active
  • HIV positive or negative
  • Latino youth ages 18-24 years
  • Residents of the state of Georgia and can understand spoken and written English or Spanish.
Read More
Exclusion Criteria
  • Unmet inclusion criteria
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Venue Testing Group- Negative TestReducing Risk BehaviorParticipants will perform a rapid HIV test and will be asked to answer questions about their sexual life and living situation. No followup is needed for a negative HIV test.
Venue Testing Group- Positive TestSupport and GuidanceParticipants will perform a rapid HIV test and will be asked to answer questions about their sexual life and living situation. Participants with a positive HIV test will receive care from a psychologist and case manager for one year.
Primary Outcome Measures
NameTimeMethod
Days to Linkage to CarePost Diagnosis (Up to 3 months)

For participants who test positive, linkage to care is measured as the number of days to seek HIV treatment.

Secondary Outcome Measures
NameTimeMethod
Change in viral loadBaseline (Post Diagnosis), One year assessment (Up to one year)

A viral load test is a lab test that measures the number of HIV virus particles in a milliliter of blood. A high viral load indicates the presence of more HIV within the body. Change is measured as the difference in viral load from baseline to the end of the study period.

Number of medical care visitsPost Diagnosis (Up to one year)

For participants who test positive, engagement to care is measured as the number of medical care visits in a six month period after diagnosis. One HIV medical care visit every six months is considered engaged.

Change in CD4 countBaseline (Post Diagnosis), One year assessment (Up to one year)

A CD4 count is a lab test that measures the number of CD4 T lymphocytes (CD4 cells) in a blood sample. A very low CD4 count (less than 200 cells/mm3) is a way to determine whether an HIV infection has progressed. Change is measured as the difference in CD4 count from baseline to the end of the study period.

Rate of venue acceptanceOne year assessment (Up to one year)

The rate of venue acceptance is measured as the number of venues that allow rapid HIV testing over he number of venues approached.

Rate of study subject acceptanceOne year assessment (Up to one year)

The rate of study subject acceptance is measured as the number of participants who agree to participate in rapid HIV testing over the number of people approached.

Change in HIV stigma scale scoreBaseline (Post Diagnosis), One year assessment (Up to one year)

The HIV stigma scale is a ten question self report measure that assesses perceived feelings of being stigmatized. Answers are reported on a scale from 0 (not at all) to 4 (extremely). A higher score indicates feelings of greater stigmatization.

Change in HIV-AIDS stress scale scoreBaseline (Post Diagnosis), One year assessment (Up to one year)

The HIV-AIDS stress scale is a self report measure that assesses perceived emotional stress related to HIV. Answers are reported on a scale from 0 (not at all) to 4 (extremely). A higher score indicates more emotional stress.

Trial Locations

Locations (2)

Grady Health System

🇺🇸

Atlanta, Georgia, United States

Ponce De Leon Center

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath